Prevymis (letermovir) - Merck (MSD)
Letermovir Prophylaxis for Cytomegalovirus Infection in Adult Chinese Liver Transplant Recipients: A Multicenter, Double-Blind, Placebo-Controlled Clinical Study. (ChiCTR) - Jan 31, 2026 - P=N/A | N=136 | Not yet recruiting | Sponsor: West China Hospital of Sichuan University; West China Hospital, Sichuan University 
New trial • Cytomegalovirus Infection • Infectious Disease • Transplantation
https://www.chictr.org.cn/showproj.html?proj=301203
 
Jan 31, 2026
 
Prev Next